- Home
- RGNX vs NBB Comparison
RGNX vs NBB Comparison
Compare RGNX & NBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGNX
- NBB
- Stock Information
- Founded
- RGNX 2008
- NBB 2009
- Country
- RGNX United States
- NBB United States
- Employees
- RGNX N/A
- NBB N/A
- Industry
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- NBB Finance Companies
- Sector
- RGNX Health Care
- NBB Finance
- Exchange
- RGNX Nasdaq
- NBB Nasdaq
- Market Cap
- RGNX 387.0M
- NBB 462.1M
- IPO Year
- RGNX 2015
- NBB N/A
- Fundamental
- Price
- RGNX $8.18
- NBB $15.38
- Analyst Decision
- RGNX Strong Buy
- NBB
- Analyst Count
- RGNX 8
- NBB 0
- Target Price
- RGNX $31.75
- NBB N/A
- AVG Volume (30 Days)
- RGNX 1.2M
- NBB 73.9K
- Earning Date
- RGNX 05-12-2025
- NBB 01-01-0001
- Dividend Yield
- RGNX N/A
- NBB 8.64%
- EPS Growth
- RGNX N/A
- NBB N/A
- EPS
- RGNX N/A
- NBB N/A
- Revenue
- RGNX $156,718,000.00
- NBB N/A
- Revenue This Year
- RGNX $285.14
- NBB N/A
- Revenue Next Year
- RGNX N/A
- NBB N/A
- P/E Ratio
- RGNX N/A
- NBB N/A
- Revenue Growth
- RGNX 80.70
- NBB N/A
- 52 Week Low
- RGNX $5.04
- NBB $13.67
- 52 Week High
- RGNX $17.52
- NBB $16.66
- Technical
- Relative Strength Index (RSI)
- RGNX 51.88
- NBB 44.94
- Support Level
- RGNX $6.89
- NBB $15.01
- Resistance Level
- RGNX $10.59
- NBB $15.70
- Average True Range (ATR)
- RGNX 0.76
- NBB 0.20
- MACD
- RGNX -0.16
- NBB 0.01
- Stochastic Oscillator
- RGNX 34.86
- NBB 33.49
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About NBB Nuveen Taxable Municipal Income Fund of Beneficial Interest
Nuveen Taxable Municipal Income Fund is a closed-end fund incorporated in the United States. Its primary objective is current income through investments in taxable municipal securities; the secondary objective is to seek enhanced portfolio value and total return. The fund invests primarily in a diversified portfolio of taxable municipal securities.